Target intelligence / Profile preview

TBC1 domain family member 14 (TBC1D14)

Target
TBC1D14
Molecular classification
Other (TBC domain-containing protein), Rab GTPase-activating protein (RabGAP) family
01

Overview

TBC1 domain family member 14 (TBC1D14) is a cytoplasmic protein characterized by a C-terminal TBC (Tre2-Bub2-Cdc16) domain typical for Rab GTPase-activating proteins (RabGAPs), although TBC1D14 does not exhibit classical RabGAP enzymatic activity. Its primary biological role is as a negative regulator of autophagy: TBC1D14 controls the delivery of membranes from RAB11-positive recycling endosomes to forming autophagosomes. It functions by interacting with the TRAPP complex—specifically with the TRAPPIII-like complex through the TRAPPC8 subunit—and modulating trafficking of ATG9, which is essential for autophagosome formation. Overexpression of TBC1D14 perturbs autophagy initiation and secretory trafficking. While it binds RAB11 and has features of a Rab effector, it does not act as a GAP for RAB11. TBC1D14 is localized to the Golgi, autophagosome, and recycling endosome. Currently, TBC1D14 is not categorized as a classical therapeutic target such as a receptor, enzyme, transporter, or ion channel[1][2][3].

Other names
TBC1D14KIAA1322TBC1 domain family member 14
02

Biological functions

Negative regulation of autophagyRecycling endosome to Golgi transportRegulation of autophagosome assemblyProtein kinase binding
03

Disease associations

Other (no direct evidence for involvement in cancer, inflammation, neurodegeneration, cardiovascular disease, or infection as of current knowledge)

Beyond the preview

Go deeper on TBC1 domain family member 14 (TBC1D14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1 domain family member 14 (TBC1D14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call